Talca Imran
Type 1 diabetes (T1D) is a chronic autoimmune condition with an increasing
global incidence, particularly among children. Early identification through
childhood screening offers the potential to mitigate complications
and improve long-term health outcomes. This article examines current
methodologies for screening, including genetic, immunologic, and
metabolic markers, while addressing their feasibility, benefits, and
challenges. Emerging technologies and their integration into large-scale
screening programs are also discussed. By evaluating the outcomes of
recent studies and trials, this review highlights the potential for childhood
screening to revolutionize T1D management and reduce disease burden.
